Incremental Cost-Effectiveness of 13-valent Pneumococcal Conjugate Vaccine for Adults Age 50 Years and Older in the United States

Title
Incremental Cost-Effectiveness of 13-valent Pneumococcal Conjugate Vaccine for Adults Age 50 Years and Older in the United States
Authors
Keywords
vaccinations, cost-effectiveness, pneumococcal disease
Journal
JOURNAL OF GENERAL INTERNAL MEDICINE
Volume 31, Issue 8, Pages 901-908
Publisher
Springer Nature
Online
2016-03-19
DOI
10.1007/s11606-016-3651-0

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation